Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Anterior Cruciate Ligament (ACL) Reconstruction Market by Product [Autografts (Vascularized Bone Autografts, Non-Vascularized Bone Autografts), Allografts (Demineralized Bone Matrix, Other Allografts)], Fixation Type (Femoral Fixation, Tibial Fixation), Indication (Osteoarthritis, Rheumatoid Arthritis, Trauma, Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) and Forecast 2024-2031

$3,000.00

Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Anterior cruciate ligament (ACL) reconstruction is a surgical tissue graft replacement of the anterior cruciate ligament, located in the knee, to restore its function after an injury. The torn ligament can either be removed from the knee (most common), or preserved (where the graft is passed inside the preserved ruptured native ligament) before reconstruction an arthroscopic procedure.

Surgery for anterior cruciate ligament (ACL) injuries involves reconstructing or repairing the ACL. ACL reconstruction surgery uses a graft to replace the ligament. The most common grafts are autografts using part of your own body, such as the tendon of the kneecap (patellar tendon) or one of the hamstring tendons. Sometimes the quadriceps tendon from above the kneecap is used. Another choice is allograft tissue, which is taken from a deceased donor.

ACL tears are not usually repaired using suture to sew it back together, because repaired ACLs have generally been shown to fail over time. Therefore, the torn ACL is generally replaced by a substitute graft made of tendon.

The global anterior cruciate ligament reconstruction market research report provides market size ($million 2021 to 2031), market share analysis, growth trends and forecast (CAGR%, 2024 to 2031).

The global anterior cruciate ligament reconstruction market segmentation is based on product [autografts (vascularized bone autografts, non-vascularized bone autografts), allografts (demineralized bone matrix, other allografts)], fixation type (femoral fixation, tibial fixation), indication (osteoarthritis, rheumatoid arthritis, trauma, others), end user (hospitals, orthopedic clinics, ambulatory surgical centers), and geography.

The global anterior cruciate ligament reconstruction market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

In addition, the global anterior cruciate ligament reconstruction market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global anterior cruciate ligament reconstruction market and profiled in this report include Arthrex, Inc., CITIEFFE S.R.L., CONMED Corporation, DJO Global Inc., Johnson & Johnson (DePuy Synthes), Meira Corporation, Smith & Nephew plc, Stryker Corporation, Wright Medical N.V, and Zimmer Biomet Holdings, Inc.

DATA INCLUDED: Anterior Cruciate Ligament Reconstruction Market Size, Anterior Cruciate Ligament Reconstruction Market Share, Anterior Cruciate Ligament Reconstruction Market Growth Rates, Anterior Cruciate Ligament Reconstruction Market Trends, and Anterior Cruciate Ligament Reconstruction Market Forecast to 2031

Market Data:

  • Base year for estimation: 2023
  • Actual estimates/Historical data: 2021-2031
  • Forecast period: 2024-2031
  • Market representation: Revenue in $million and CAGR % from 2024 to 2031
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: Any specific or custom requirements, which is not currently within the scope of the report, will be provided as a part of customization.

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Please contact us for offers on individual or multiple report purchases.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2021-2031)
    • Forecast Estimation ($million and CAGR%, 2024-2031)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Anterior Cruciate Ligament Reconstruction Market

1. Product
1.1. Autograft
1.2. Vascularızed bone autografts (VBG)
1.3. Non-vascularized bone autografts (NVBG)
1.4. Allograft
1.5. Demineralized Bone Matrix (DBM)
1.6. Other Allografts

2. Fixation Type
2.1. Femoral Fixation (Thigh bone)
2.2. Tibial Fixation (Knee bone)

3. Indication
3.1. Osteoarthritis
3.2. Rheumatoid Arthritis
3.3. Trauma
3.4. Others

4. End User
4.1. Hospitals
4.2. Orthopedic Clinics
4.3. Ambulatory Surgical Centers

5. Geography
5.1. North America (U.S., Canada)
5.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
5.3. Asia Pacific (Japan, China, India, Rest of APAC)
5.4. Latin America (Brazil, Mexico, Rest of LA)
5.5. Rest of the World

6. Company Profiles
6.1. Arthrex, Inc.
6.2. CITIEFFE S.R.L.
6.3. CONMED Corporation
6.4. DJO Global Inc.
6.5. Johnson & Johnson (DePuy Synthes)
6.6. Meira Corporation
6.7. Smith & Nephew plc
6.8. Stryker Corporation
6.9. Wright Medical N.V
6.10. Zimmer Biomet Holdings, Inc.

    Request ToC / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com